Promatix Biosciences Presents Positive Preclinical Data with First-in-Class PBS293 EGFR×EphA2 Cis-Bispecific ADC Demonstrating Enhanced Tumour Selectivity

Data presented at 16th World ADC London Summit with lead programme in colorectal cancer highlight the promise of Promatix’s proteomics-based ...
ascopubs.org

EGFR over-expression in squamous cell carcinoma of the penis

Combination of estramustine, paclitaxel, and tegafur-uracil (ETU) in patients with metastatic hormone-refractory prostate cancer (mHRPC): Efficacy and safety results of a multicenter phase II study No ...
ascopubs.org

Role of cMET expression in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.

Effect of loss of a chromosome 7 containing multiple copies of EGFR gene on acquired resistance to EGFR-TKIs in EGFR mutated NSCLC. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I ...
EurekAlert!

EGFR inhibitor-linked cytokine storms: study uncovers the trigger

Schematic diagram of the IL-6/JAK/STAT3 signaling pathway activation in mouse liver macrophages. IRs, inhibitory receptors (IRs); ICIs, immune checkpoint inhibitors; IL-6, interleukin-6; ALT, alanine ...
Healio

Cystatin C- and creatinine-based eGFR discrepancies linked to adverse kidney, CV outcomes

Please provide your email address to receive an email when new articles are posted on . More inpatients had a discrepancy in eGFR compared with outpatients. Characteristics associated with a large ...